Cantor Fitzgerald Stock Ratings and Recommendations

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Cantor Fitzgerald. These ratings and price targets were collected from pubilc media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Cantor Fitzgerald.

DateBrokerageActionCompany
Name
RatingPrice
Target
Impact on
Share Price
Actions
5/16/2018Cantor FitzgeraldReiteratesNational Health Investors (NHI)NeutralN/AView Rating Details  Share on Twitter  Share on StockTwits
5/16/2018Cantor FitzgeraldReiteratesLTC Properties (LTC)OverweightN/AView Rating Details  Share on Twitter  Share on StockTwits
5/16/2018Cantor FitzgeraldReiteratesbluebird bio (BLUE)UnderweightN/AView Rating Details  Share on Twitter  Share on StockTwits
5/18/2018Cantor FitzgeraldReiteratesCorium International (CORI)Buy $14.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/17/2018Cantor FitzgeraldSet Price TargetTeva Pharmaceutical Industries (TEVA)Hold $18.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/18/2018Cantor FitzgeraldRaises TargeteHealth (EHTH)Overweight $22.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/17/2018Cantor FitzgeraldReiteratesCerner (CERN)Buy $70.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/16/2018Cantor FitzgeraldSet Price TargetDynavax Technologies (DVAX)Buy $27.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/16/2018Cantor FitzgeraldSet Price TargetCytomX Therapeutics (CTMX)Buy $40.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/15/2018Cantor FitzgeraldSet Price TargetAldeyra Therapeutics (ALDX)Buy $23.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/16/2018Cantor FitzgeraldReiteratesAbeona Therapeutics (ABEO)Buy $36.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/16/2018Cantor FitzgeraldSet Price TargetIsotechnika Pharma (AUPH)Buy $16.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/16/2018Cantor FitzgeraldReiteratesZoetis (ZTS)Buy $98.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/16/2018Cantor FitzgeraldReiteratesFive Star Senior Living (FVE)Overweight $3.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/14/2018Cantor FitzgeraldSet Price TargetPerrigo (PRGO)Buy $107.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/14/2018Cantor FitzgeraldReiteratesathenahealth (ATHN)Hold $140.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/14/2018Cantor FitzgeraldSet Price TargetAmarin (AMRN)Buy $10.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/14/2018Cantor FitzgeraldSet Price TargetValeant Pharmaceuticals International (VRX)Buy $25.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/10/2018Cantor FitzgeraldSet Price TargetSpero Therapeutics (SPRO)Buy $27.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/10/2018Cantor FitzgeraldSet Price TargetCidara Therapeutics (CDTX)Buy $15.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/11/2018Cantor FitzgeraldReiteratesViewray (VRAY)Buy $13.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/11/2018Cantor FitzgeraldReiteratesRadius Health (RDUS)Buy $58.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/10/2018Cantor FitzgeraldReiteratesLTC Properties (LTC)Buy $45.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/10/2018Cantor FitzgeraldReiteratesCastlight Health (CSLT)Buy $5.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/10/2018Cantor FitzgeraldReiteratesIsotechnika Pharma (AUPH)Buy $16.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/10/2018Cantor FitzgeraldSet Price TargetCorbus Pharmaceuticals (CRBP)Buy $32.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/10/2018Cantor FitzgeraldSet Price TargetArsanis (ASNS)Buy $26.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/10/2018Cantor FitzgeraldSet Price TargetHeron Therapeutics (HRTX)Buy $40.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/10/2018Cantor FitzgeraldSet Price TargetStrongbridge Biopharma (SBBP)Buy $14.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018Cantor FitzgeraldSet Price TargetGlobal Blood Therapeutics (GBT)Buy $69.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018Cantor FitzgeraldSet Price TargetSpring Bank Pharma (SBPH)Buy $32.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018Cantor FitzgeraldSet Price TargetZynerba Pharmaceuticals (ZYNE)Buy $20.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/10/2018Cantor FitzgeraldReiteratesWorldpay (WP)Buy $92.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/10/2018Cantor FitzgeraldReiteratesbluebird bio (BLUE)Sell $122.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018Cantor FitzgeraldSet Price TargetCytomX Therapeutics (CTMX)Buy $40.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018Cantor FitzgeraldSet Price TargetArray Biopharma (ARRY)Buy $24.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018Cantor FitzgeraldSet Price TargetBellicum Pharmaceuticals (BLCM)Buy $18.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018Cantor FitzgeraldReiteratesSabra Health Care REIT (SBRA)Buy $25.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018Cantor FitzgeraldSet Price TargetMylan (MYL)Hold $41.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018Cantor FitzgeraldSet Price TargetProgenics Pharmaceuticals (PGNX)Buy $15.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018Cantor FitzgeraldSet Price TargetHorizon Pharma (HZNP)Buy $17.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018Cantor FitzgeraldSet Price TargetMajesco Entertainment (COOL)Buy $70.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018Cantor FitzgeraldReiteratesNeos Therapeutics (NEOS)Buy $20.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018Cantor FitzgeraldSet Price TargetParatek Pharmaceuticals (PRTK)Buy $50.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018Cantor FitzgeraldRaises TargetGartner (IT)Overweight $148.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018Cantor FitzgeraldReiteratesEPAM Systems (EPAM)Buy $139.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018Cantor FitzgeraldReiteratesAimmune Therapeutics (AIMT)Buy $64.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018Cantor FitzgeraldSet Price TargetRevance Therapeutics (RVNC)Buy $50.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018Cantor FitzgeraldSet Price TargetAerie Pharmaceuticals (AERI)Buy $86.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018Cantor FitzgeraldSet Price TargetTheravance Biopharma (TBPH)Buy $55.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018Cantor FitzgeraldReiteratesDynavax Technologies (DVAX)Buy $27.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018Cantor FitzgeraldInitiatesCareTrust REIT (CTRE)Buy $16.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018Cantor FitzgeraldReiteratesOPKO Health (OPK)Buy $20.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018Cantor FitzgeraldUpgradesArrowhead Pharmaceuticals (ARWR)Neutral -> Overweight $13.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018Cantor FitzgeraldSet Price TargetNabriva Therapeutics (NBRV)Buy $16.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018Cantor FitzgeraldSet Price TargetAclaris Therapeutics (ACRS)Buy $50.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018Cantor FitzgeraldSet Price TargetOcular Therapeutix (OCUL)Buy $22.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018Cantor FitzgeraldSet Price TargetSpark Therapeutics (ONCE)Buy $103.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018Cantor FitzgeraldSet Price TargetPerrigo (PRGO)Buy $107.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018Cantor FitzgeraldSet Price TargetEndo International (ENDP)Hold $7.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018Cantor FitzgeraldReiteratesMallinckrodt (MNK)Buy $42.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018Cantor FitzgeraldDowngradesEgalet (EGLT)Overweight -> Hold $2.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018Cantor FitzgeraldSet Price TargetValeant Pharmaceuticals International (VRX)Buy $25.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018Cantor FitzgeraldReiteratesIntercept Pharmaceuticals (ICPT)Hold $58.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018Cantor FitzgeraldReiteratesNational Health Investors (NHI)Hold $75.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/7/2018Cantor FitzgeraldReiteratesPhysicians Realty Trust (DOC)Buy $18.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/7/2018Cantor FitzgeraldReiteratesCross Country Healthcare (CCRN)Hold $11.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/7/2018Cantor FitzgeraldSet Price TargetBioDelivery Sciences International (BDSI)Buy $5.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/7/2018Cantor FitzgeraldReiteratesAllergan (AGN)Hold $180.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/5/2018Cantor FitzgeraldSet Price TargetCelgene (CELG)Hold $112.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018Cantor FitzgeraldSet Price TargetDermira (DERM)Buy $20.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018Cantor FitzgeraldSet Price TargetTeva Pharmaceutical Industries (TEVA)Hold $18.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018Cantor FitzgeraldSet Price TargetNewLink Genetics (NLNK)Hold $7.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/4/2018Cantor FitzgeraldRaises TargetEnsign Group (ENSG)Overweight $35.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/4/2018Cantor FitzgeraldDowngradesU.S. Physical Therapy (USPH)Overweight -> NeutralLowView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018Cantor FitzgeraldReiteratesAllscripts (MDRX)Buy $18.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018Cantor FitzgeraldReiteratesU.S. Physical Therapy (USPH)Overweight -> Buy $90.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018Cantor FitzgeraldReiteratesMSCI (MSCI)Buy $163.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/2/2018Cantor FitzgeraldSet Price TargetVerastem (VSTM)Buy $17.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018Cantor FitzgeraldReiteratesMastercard (MA)Overweight $213.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/2/2018Cantor FitzgeraldReiteratesHealth Insurance Innovations (HIIQ)Buy $60.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/2/2018Cantor FitzgeraldReiteratesAAC (AAC)Buy $14.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/2/2018Cantor FitzgeraldSet Price TargetAmarin (AMRN)Buy $10.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/1/2018Cantor FitzgeraldSet Price TargetRigel Pharmaceuticals (RIGL)Overweight -> Overweight$6.00 -> $9.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/1/2018Cantor FitzgeraldReiteratesCommunity Health Systems (CYH)Hold $6.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/1/2018Cantor FitzgeraldUpgradesAetna (AET)Neutral -> OverweightMediumView Rating Details  Share on Twitter  Share on StockTwits
5/1/2018Cantor FitzgeraldLowers TargetAllergan (AGN)Neutral -> Neutral$191.00 -> $180.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/1/2018Cantor FitzgeraldSet Price TargetZoetis (ZTS)Buy $90.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/1/2018Cantor FitzgeraldReiteratesAxoGen (AXGN)Overweight -> Overweight$37.00 -> $45.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/30/2018Cantor FitzgeraldSet Price TargetMallinckrodt (MNK)Buy $42.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/30/2018Cantor FitzgeraldSet Price TargetKaryopharm Therapeutics (KPTI)Buy $18.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/30/2018Cantor FitzgeraldReiteratesJazz Pharmaceuticals (JAZZ)Buy $202.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/30/2018Cantor FitzgeraldSet Price TargetSpero Therapeutics (SPRO)Buy $27.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/30/2018Cantor FitzgeraldReiteratesSpark Therapeutics (ONCE)Overweight -> Buy$100.00 -> $103.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/27/2018Cantor FitzgeraldSet Price TargetAllergan (AGN)Hold $191.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/26/2018Cantor FitzgeraldSet Price TargetSeattle Genetics (SGEN)Hold $50.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/27/2018Cantor FitzgeraldReiteratesStryker (SYK)Hold -> NeutralHighView Rating Details  Share on Twitter  Share on StockTwits
4/26/2018Cantor FitzgeraldReiteratesBiogen (BIIB)NeutralMediumView Rating Details  Share on Twitter  Share on StockTwits
4/25/2018Cantor FitzgeraldSet Price TargetZynerba Pharmaceuticals (ZYNE)Buy $20.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/25/2018Cantor FitzgeraldReiteratesEvolus (EOLS)Buy $25.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/25/2018Cantor FitzgeraldReiteratesCastlight Health (CSLT)Buy $5.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/25/2018Cantor FitzgeraldReiteratesAccenture (ACN)Buy $180.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/25/2018Cantor FitzgeraldReiteratesAnthem (ANTM)Buy $275.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/24/2018Cantor FitzgeraldSet Price TargetKaryopharm Therapeutics (KPTI)Buy $18.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/24/2018Cantor FitzgeraldSet Price TargetCytokinetics (CYTK)Hold $10.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/24/2018Cantor FitzgeraldSet Price TargetZoetis (ZTS)Buy $90.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/24/2018Cantor FitzgeraldReiteratesProthena (PRTA)Overweight -> Overweight$69.00 -> $14.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/23/2018Cantor FitzgeraldReiteratesTivity Health (TVTY)Buy $53.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/23/2018Cantor FitzgeraldReiteratesHumana (HUM)Hold $250.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/22/2018Cantor FitzgeraldSet Price TargetHeron Therapeutics (HRTX)Buy $40.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/20/2018Cantor FitzgeraldReiteratesExponent (EXPO)Buy $96.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/19/2018Cantor FitzgeraldRaises TargetGW Pharmaceuticals (GWPH)Overweight -> Overweight$192.00 -> $205.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/19/2018Cantor FitzgeraldReiteratesSyntel (SYNT)Hold -> NeutralHighView Rating Details  Share on Twitter  Share on StockTwits
4/18/2018Cantor FitzgeraldRaises TargetUnitedHealth Group (UNH)Overweight $300.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/18/2018Cantor FitzgeraldRaises TargetIntuitive Surgical (ISRG)Overweight $510.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/17/2018Cantor FitzgeraldSet Price TargetGW Pharmaceuticals (GWPH)Buy $192.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/17/2018Cantor FitzgeraldSet Price TargetRigel Pharmaceuticals (RIGL)Buy $6.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/17/2018Cantor FitzgeraldDowngradesCelldex Therapeutics (CLDX)Overweight -> Neutral $3.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/16/2018Cantor FitzgeraldSet Price TargetDynavax Technologies (DVAX)Buy $27.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/16/2018Cantor FitzgeraldSet Price TargetShire (SHPG)Buy $222.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/15/2018Cantor FitzgeraldSet Price TargetHorizon Pharma (HZNP)Buy $17.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/16/2018Cantor FitzgeraldSet Price TargetNewLink Genetics (NLNK)Hold $7.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/13/2018Cantor FitzgeraldReiteratesAclaris Therapeutics (ACRS)Buy $50.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/13/2018Cantor FitzgeraldReiteratesCoupa (COUP)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
4/12/2018Cantor FitzgeraldSet Price TargetAllergan (AGN)Hold $191.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/12/2018Cantor FitzgeraldSet Price TargetSpero Therapeutics (SPRO)Buy $27.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/12/2018Cantor FitzgeraldReiteratesAmarin (AMRN)Buy $10.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/11/2018Cantor FitzgeraldSet Price TargetMylan (MYL)Hold $41.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/11/2018Cantor FitzgeraldReiteratesBellicum Pharmaceuticals (BLCM)Overweight -> Overweight$10.00 -> $18.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/10/2018Cantor FitzgeraldReiteratesExela Technologies (XELA)Buy $9.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/9/2018Cantor FitzgeraldSet Price TargetShire (SHPG)Buy $222.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/9/2018Cantor FitzgeraldSet Price TargetVerastem (VSTM)Buy $17.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/9/2018Cantor FitzgeraldSet Price TargetDermira (DERM)Buy $20.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/9/2018Cantor FitzgeraldDowngradesNewLink Genetics (NLNK)Overweight -> Neutral$26.00 -> $7.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/8/2018Cantor FitzgeraldSet Price TargetImmunoGen (IMGN)Hold $5.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/6/2018Cantor FitzgeraldSet Price TargetHeron Therapeutics (HRTX)Buy $40.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/6/2018Cantor FitzgeraldSet Price TargetAclaris Therapeutics (ACRS)Buy $50.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/6/2018Cantor FitzgeraldSet Price TargetNewLink Genetics (NLNK)Buy $26.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/5/2018Cantor FitzgeraldSet Price TargetStrongbridge Biopharma (SBBP)Buy $14.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/5/2018Cantor FitzgeraldSet Price TargetParatek Pharmaceuticals (PRTK)Buy $50.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/5/2018Cantor FitzgeraldReiteratesAllscripts (MDRX)Buy $18.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/3/2018Cantor FitzgeraldReiteratesAccenture (ACN)OverweightMediumView Rating Details  Share on Twitter  Share on StockTwits
4/4/2018Cantor FitzgeraldSet Price TargetAmarin (AMRN)Buy $10.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/3/2018Cantor FitzgeraldReiteratesOmnicell Technologies (OMCL)Buy $63.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/3/2018Cantor FitzgeraldReiteratesRigel Pharmaceuticals (RIGL)Buy $6.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/2/2018Cantor FitzgeraldSet Price TargetMallinckrodt (MNK)Buy $42.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/2/2018Cantor FitzgeraldSet Price TargetCelgene (CELG)Hold $112.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/2/2018Cantor FitzgeraldReiteratesRevance Therapeutics (RVNC)Buy $50.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/2/2018Cantor FitzgeraldReiteratesSpero Therapeutics (SPRO)Buy $27.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/2/2018Cantor FitzgeraldLowers TargetAlkermes (ALKS)Neutral $45.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/2/2018Cantor FitzgeraldReiteratesCentene (CNC)Buy $125.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/29/2018Cantor FitzgeraldReiteratesXencor (XNCR)Buy $37.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/29/2018Cantor FitzgeraldSet Price TargetAldeyra Therapeutics (ALDX)Buy $23.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/28/2018Cantor FitzgeraldInitiatesTahoe Resources (TAHO)BuyMediumView Rating Details  Share on Twitter  Share on StockTwits
3/28/2018Cantor FitzgeraldSet Price TargetShire (SHPG)Buy $222.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/28/2018Cantor FitzgeraldRaises TargetIHS Markit (INFO)Neutral -> Neutral$47.00 -> $51.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/28/2018Cantor FitzgeraldRaises TargetFactSet (FDS)Neutral -> Neutral$187.00 -> $203.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/27/2018Cantor FitzgeraldReiteratesCorium International (CORI)Buy $14.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/27/2018Cantor FitzgeraldReiteratesVocera Communications (VCRA)Buy $35.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/27/2018Cantor FitzgeraldSet Price TargetDermira (DERM)Buy $20.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/27/2018Cantor FitzgeraldSet Price TargetFlex Pharma (FLKS)Hold $6.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/25/2018Cantor FitzgeraldSet Price TargetImmunoGen (IMGN)Hold $5.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/23/2018Cantor FitzgeraldReiteratesHealthEquity (HQY)Buy $65.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/23/2018Cantor FitzgeraldSet Price TargetNeos Therapeutics (NEOS)Buy $20.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/23/2018Cantor FitzgeraldSet Price TargetGlaukos (GKOS)Buy $43.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/22/2018Cantor FitzgeraldSet Price TargetProgenics Pharmaceuticals (PGNX)Buy $15.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/22/2018Cantor FitzgeraldSet Price TargetRadius Health (RDUS)Buy $58.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/21/2018Cantor FitzgeraldSet Price TargetKaryopharm Therapeutics (KPTI)Buy $18.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/21/2018Cantor FitzgeraldReiteratesProthena (PRTA)Overweight $69.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/20/2018Cantor FitzgeraldSet Price TargetSeattle Genetics (SGEN)Hold $50.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/20/2018Cantor FitzgeraldSet Price TargetAbeona Therapeutics (ABEO)Buy $36.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/20/2018Cantor FitzgeraldSet Price TargetMajesco Entertainment (COOL)Buy $70.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/19/2018Cantor FitzgeraldSet Price TargetHeron Therapeutics (HRTX)Buy $40.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/19/2018Cantor FitzgeraldSet Price TargetCidara Therapeutics (CDTX)Buy $15.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/19/2018Cantor FitzgeraldSet Price TargetAclaris Therapeutics (ACRS)Buy $50.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/17/2018Cantor FitzgeraldSet Price TargetCytomX Therapeutics (CTMX)Buy $40.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/17/2018Cantor FitzgeraldSet Price TargetArdelyx (ARDX)Buy $12.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/16/2018Cantor FitzgeraldLowers TargetHealthcare Realty Trust (HR)Overweight $34.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/16/2018Cantor FitzgeraldSet Price TargetNabriva Therapeutics (NBRV)Buy $16.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/16/2018Cantor FitzgeraldReiteratesCymaBay Therapeutics (CBAY)Buy $16.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/15/2018Cantor FitzgeraldReiteratesBioDelivery Sciences International (BDSI)Buy $5.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/15/2018Cantor FitzgeraldSet Price TargetIsotechnika Pharma (AUPH)Overweight -> Overweight$14.00 -> $16.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/15/2018Cantor FitzgeraldSet Price TargetNeos Therapeutics (NEOS)Buy $20.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/15/2018Cantor FitzgeraldReiteratesNovavax (NVAX)Hold $2.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/15/2018Cantor FitzgeraldSet Price TargetKaryopharm Therapeutics (KPTI)Buy $18.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/15/2018Cantor FitzgeraldSet Price TargetArsanis (ASNS)Buy $26.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/14/2018Cantor FitzgeraldReiteratesHorizon Pharma (HZNP)Buy $17.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/14/2018Cantor FitzgeraldReiteratesCerner (CERN)Buy $80.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/13/2018Cantor FitzgeraldSet Price TargetBellicum Pharmaceuticals (BLCM)Buy $10.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/13/2018Cantor FitzgeraldReiteratesVerastem (VSTM)Buy $17.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/13/2018Cantor FitzgeraldInitiatesR1 RCM (RCM)Overweight $9.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/13/2018Cantor FitzgeraldReiteratesVirtusa (VRTU)Buy -> Buy$52.00 -> $60.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/13/2018Cantor FitzgeraldLowers TargetEgalet (EGLT)Overweight -> Overweight$7.00 -> $3.50HighView Rating Details  Share on Twitter  Share on StockTwits
3/13/2018Cantor FitzgeraldRaises TargetCoupa (COUP)Overweight -> Overweight$38.00 -> $58.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/12/2018Cantor FitzgeraldSet Price TargetPublic Storage (PSA)Hold $213.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/12/2018Cantor FitzgeraldSet Price TargetCorbus Pharmaceuticals (CRBP)Buy $32.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/12/2018Cantor FitzgeraldSet Price TargetZynerba Pharmaceuticals (ZYNE)Buy $20.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/13/2018Cantor FitzgeraldLowers TargetAdvaxis (ADXS)Hold -> Overweight$19.00 -> $5.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/12/2018Cantor FitzgeraldSet Price TargetEgalet (EGLT)Buy $4.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/12/2018Cantor FitzgeraldReiteratesAclaris Therapeutics (ACRS)Buy $50.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/12/2018Cantor FitzgeraldReiteratesStrongbridge Biopharma (SBBP)Buy $14.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/12/2018Cantor FitzgeraldSet Price TargetAmarin (AMRN)Buy $10.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/11/2018Cantor FitzgeraldSet Price TargetGenocea Biosciences (GNCA)Buy $5.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/9/2018Cantor FitzgeraldRaises TargetU.S. Physical Therapy (USPH)Overweight $90.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/9/2018Cantor FitzgeraldSet Price TargetCascadian Therapeutics (CASC)Hold $10.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/9/2018Cantor FitzgeraldSet Price TargetCubeSmart (CUBE)Buy $31.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/9/2018Cantor FitzgeraldSet Price TargetArsanis (ASNS)Buy $26.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/8/2018Cantor FitzgeraldReiteratesSunesis Pharmaceuticals (SNSS)Hold $4.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/8/2018Cantor FitzgeraldSet Price TargetExtra Space Storage (EXR)Hold $86.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/8/2018Cantor FitzgeraldSet Price TargetCidara Therapeutics (CDTX)Buy $15.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/8/2018Cantor FitzgeraldSet Price TargetLife Storage (LSI)Hold $84.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/8/2018Cantor FitzgeraldSet Price TargetProgenics Pharmaceuticals (PGNX)Buy $15.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/8/2018Cantor FitzgeraldReiteratesDynavax Technologies (DVAX)Overweight -> Overweight$25.00 -> $27.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/8/2018Cantor FitzgeraldReiteratesOcular Therapeutix (OCUL)Buy $22.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/8/2018Cantor FitzgeraldReiteratesUnitedHealth Group (UNH)Buy $280.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/8/2018Cantor FitzgeraldSet Price TargetCytomX Therapeutics (CTMX)Buy $40.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/7/2018Cantor FitzgeraldReiteratesCelldex Therapeutics (CLDX)Buy $9.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/7/2018Cantor FitzgeraldInitiatesGlobal Medical REIT (GMRE)Buy $12.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/7/2018Cantor FitzgeraldReiteratesFlex Pharma (FLKS)Hold $6.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/7/2018Cantor FitzgeraldSet Price TargetShire (SHPG)Buy $222.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/7/2018Cantor FitzgeraldReiteratesOmega Healthcare Investors (OHI)Buy $34.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/6/2018Cantor FitzgeraldReiteratesRigel Pharmaceuticals (RIGL)Buy $7.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/6/2018Cantor FitzgeraldReiteratesAllscripts (MDRX)Buy $18.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/6/2018Cantor FitzgeraldReiterateseHealth (EHTH)Buy $20.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/6/2018Cantor FitzgeraldSet Price TargetTIER REIT (TIER)Buy $22.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/5/2018Cantor FitzgeraldReiteratesAduro BioTech (ADRO)Buy $15.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/5/2018Cantor FitzgeraldInitiatesCareTrust REIT (CTRE)Overweight $16.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/5/2018Cantor FitzgeraldInitiatesGenocea Biosciences (GNCA)Overweight $5.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/5/2018Cantor FitzgeraldSet Price TargetAshford Hospitality Trust (AHT)Buy $8.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/5/2018Cantor FitzgeraldReiteratesCerner (CERN)Buy $80.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/5/2018Cantor FitzgeraldSet Price TargetDermira (DERM)Buy $20.00N/AView Rating Details  Share on Twitter  Share on StockTwits
3/5/2018Cantor FitzgeraldInitiatesZynerba Pharmaceuticals (ZYNE)Buy $17.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/5/2018Cantor FitzgeraldReiteratesAimmune Therapeutics (AIMT)Overweight $64.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/5/2018Cantor FitzgeraldInitiatesEvolus (EOLS)Overweight $25.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/2/2018Cantor FitzgeraldSet Price TargetNewLink Genetics (NLNK)Buy $26.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/2/2018Cantor FitzgeraldDowngradesCross Country Healthcare (CCRN)Overweight -> NeutralHighView Rating Details  Share on Twitter  Share on StockTwits
3/1/2018Cantor FitzgeraldSet Price TargetOPKO Health (OPK)Buy $20.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/1/2018Cantor FitzgeraldSet Price TargetOmeros (OMER)Hold $19.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/1/2018Cantor FitzgeraldSet Price TargetPerrigo (PRGO)Buy $107.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/1/2018Cantor FitzgeraldReiteratesIntra-Cellular Therapies (ITCI)Buy $28.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/1/2018Cantor FitzgeraldReiteratesLTC Properties (LTC)Buy $52.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/1/2018Cantor FitzgeraldSet Price TargetChatham Lodging (CLDT)Hold $20.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/1/2018Cantor FitzgeraldSet Price TargetParatek Pharmaceuticals (PRTK)Buy $50.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/1/2018Cantor FitzgeraldSet Price TargetImpax Laboratories (IPXL)Buy $35.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/1/2018Cantor FitzgeraldReiteratesXencor (XNCR)Overweight $37.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/1/2018Cantor FitzgeraldReiteratesHealth Insurance Innovations (HIIQ)Overweight $60.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/28/2018Cantor FitzgeraldSet Price TargetAerie Pharmaceuticals (AERI)Buy $86.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/28/2018Cantor FitzgeraldSet Price TargetRevance Therapeutics (RVNC)Buy $50.00MediumView Rating Details  Share on Twitter  Share on StockTwits
2/28/2018Cantor FitzgeraldSet Price TargetGlaukos (GKOS)Buy -> Buy$48.00 -> $43.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/1/2018Cantor FitzgeraldSet Price TargetMylan (MYL)Hold $41.00MediumView Rating Details  Share on Twitter  Share on StockTwits

This page was last refreshed on Sunday at 01:41 PM ET.

MarketBeat Community Rating for Cantor Fitzgerald

Community Ranking:  0.0 out of 5 (star star)
Outperform Votes:  0 (Vote Outperform)
Underperform Votes:  5,750 (Vote Underperform)
Total Votes:  5,750
MarketBeat's community ratings are surveys of what our community members think about Cantor Fitzgerald and other research firms. Vote "Outperform" if you believe Cantor Fitzgerald's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Cantor Fitzgerald's recmomendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.